Abstract:Quantification of EVLW in patients who can be considered euvolemic induces important modifications in fluid and vasoactive therapy. These changes generally resulted in a lower volume loading and a positive outcome for the patient.
“…There is good evidence regarding the efficacy of goal-directed fluid management based on transpulmonary thermodilution-measured variables using the PiCCO Ò monitoring system (Pulsion Medical Systems, Munich, Germany) [14][15][16]. This has been shown to provide optimal volume management for critically ill patients with necrotising pancreatitis [15], and to reduce the vasopressor requirements of cardiac surgery patients [14].…”
mentioning
confidence: 99%
“…In a human autopsy study, we previously validated the accuracy of extravascular lung water measurements in the postmortem lung, and defined normal values [17]. The inclusion of such criteria into the therapeutic decision making process has been shown to influence fluid therapy in hypoxaemic patients [16]. Moreover, pulmonary vascular permeability index values can be used to differentiate between cardiogenic and non-cardiogenic pulmonary oedema [18], and these have been shown to correlate with the levels of plasma elastase, which is a biological mediator that alters the pulmonary vascular permeability in patients with severe pneumonia [19].…”
SummaryThe aim of the present study was to determine the precision of the PiCCO Ò system for post-cardiac arrest patients who underwent therapeutic hypothermia. The precision of the measurements for cardiac output, global end-diastolic volume, extravascular lung water and the pulmonary vascular permeability index was assessed using the least significant change; this was regarded as precise when less than 15%. A total of 462 measurement sets were prospectively performed on 88 patients following successful resuscitation after cardiac arrest. Using the mean value of three injections for a measurement, the least significant change for the cardiac output, global end-diastolic volume, extravascular lung water and pulmonary vascular permeability index measurements were found to be 7.8%, 8.5%, 7.8% and 12.1%, respectively. No significant differences between hypothermia (n = 150) and non-hypothermia (n = 312) were found. The PiCCO-derived variables were found to be precise for post-cardiac arrest patients even under conditions of varying body temperature.
“…There is good evidence regarding the efficacy of goal-directed fluid management based on transpulmonary thermodilution-measured variables using the PiCCO Ò monitoring system (Pulsion Medical Systems, Munich, Germany) [14][15][16]. This has been shown to provide optimal volume management for critically ill patients with necrotising pancreatitis [15], and to reduce the vasopressor requirements of cardiac surgery patients [14].…”
mentioning
confidence: 99%
“…In a human autopsy study, we previously validated the accuracy of extravascular lung water measurements in the postmortem lung, and defined normal values [17]. The inclusion of such criteria into the therapeutic decision making process has been shown to influence fluid therapy in hypoxaemic patients [16]. Moreover, pulmonary vascular permeability index values can be used to differentiate between cardiogenic and non-cardiogenic pulmonary oedema [18], and these have been shown to correlate with the levels of plasma elastase, which is a biological mediator that alters the pulmonary vascular permeability in patients with severe pneumonia [19].…”
SummaryThe aim of the present study was to determine the precision of the PiCCO Ò system for post-cardiac arrest patients who underwent therapeutic hypothermia. The precision of the measurements for cardiac output, global end-diastolic volume, extravascular lung water and the pulmonary vascular permeability index was assessed using the least significant change; this was regarded as precise when less than 15%. A total of 462 measurement sets were prospectively performed on 88 patients following successful resuscitation after cardiac arrest. Using the mean value of three injections for a measurement, the least significant change for the cardiac output, global end-diastolic volume, extravascular lung water and pulmonary vascular permeability index measurements were found to be 7.8%, 8.5%, 7.8% and 12.1%, respectively. No significant differences between hypothermia (n = 150) and non-hypothermia (n = 312) were found. The PiCCO-derived variables were found to be precise for post-cardiac arrest patients even under conditions of varying body temperature.
“…central venous pressure), the implementation of EVLW based protocol in the therapeutic management resulted in a change in original treatment plan in 52% of the patients (Figure 4). This clinical protocol was effective in 82% of the patients 63 .…”
Section: Use Of Evlw To Guide Fluid Therapymentioning
“…Early resolution of edema is critical for recovery from ARDS due to the development of pulmonary edema, which can impair gas exchange, causing refractory hypoxemia, and an early diagnosis of the pathological accumulation of EVLW ( Figure 2)during resuscitation could allow for earlier intervention times and considerable changes in the therapeutic plan (Pino-Sanchez et al 2009). In this study, we chose 8 ml/ kg (Michard et al 2012) as a cut-off for normal EVLW, not the urine output and oxygen delivery were increased ( p ϭ 0.0358, p ϭ 0.0090, respectively).…”
Section: Ventilator Function and Perfusion Parameter Variablesmentioning
During the early stage of septic shock-induced ARDS, dobutamine treatment demonstrated a beneficial effect by relieving pulmonary edema in patients, without a negative elevation in preload or hemodynamics, which might account for the improvements in ventilator function and tissue hypoperfusion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.